CN1178667C - 适用于治疗老年性痴呆的平均分子量为2400d的糖胺聚糖 - Google Patents

适用于治疗老年性痴呆的平均分子量为2400d的糖胺聚糖 Download PDF

Info

Publication number
CN1178667C
CN1178667C CNB00807562XA CN00807562A CN1178667C CN 1178667 C CN1178667 C CN 1178667C CN B00807562X A CNB00807562X A CN B00807562XA CN 00807562 A CN00807562 A CN 00807562A CN 1178667 C CN1178667 C CN 1178667C
Authority
CN
China
Prior art keywords
glycosaminoglycans
molecular weight
compositions
treatment
average molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB00807562XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1350459A (zh
Inventor
�̱��С��ƶ�����
翁贝托·科尔内利
°
鲁吉·德安布罗西
艾斯瑞尔·哈宁
卓维德·法理德
约翰·李
斯坦利·洛兰兹
��F��Ĭά˹
罗纳德·F·默维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1350459A publication Critical patent/CN1350459A/zh
Application granted granted Critical
Publication of CN1178667C publication Critical patent/CN1178667C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
CNB00807562XA 1999-05-14 2000-05-12 适用于治疗老年性痴呆的平均分子量为2400d的糖胺聚糖 Expired - Fee Related CN1178667C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI99A001066 1999-05-14
IT1999MI001066A IT1312107B1 (it) 1999-05-14 1999-05-14 Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile

Publications (2)

Publication Number Publication Date
CN1350459A CN1350459A (zh) 2002-05-22
CN1178667C true CN1178667C (zh) 2004-12-08

Family

ID=11382970

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB00807562XA Expired - Fee Related CN1178667C (zh) 1999-05-14 2000-05-12 适用于治疗老年性痴呆的平均分子量为2400d的糖胺聚糖

Country Status (22)

Country Link
US (1) US6979680B1 (enExample)
EP (1) EP1181024B1 (enExample)
JP (1) JP2002544233A (enExample)
KR (1) KR100711142B1 (enExample)
CN (1) CN1178667C (enExample)
AT (1) ATE288761T1 (enExample)
AU (1) AU764743C (enExample)
CA (1) CA2373975A1 (enExample)
CZ (1) CZ20014092A3 (enExample)
DE (1) DE60018061T2 (enExample)
DK (1) DK1181024T3 (enExample)
ES (1) ES2237425T3 (enExample)
HK (1) HK1039903B (enExample)
HU (1) HUP0201100A3 (enExample)
IL (1) IL146458A0 (enExample)
IT (1) IT1312107B1 (enExample)
NO (1) NO328902B1 (enExample)
PL (1) PL198016B1 (enExample)
PT (1) PT1181024E (enExample)
RU (1) RU2248800C2 (enExample)
WO (1) WO2000069444A1 (enExample)
ZA (1) ZA200109331B (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8766217B2 (en) 2008-05-22 2014-07-01 Vladimir Yegorovich Balakin Multi-field charged particle cancer therapy method and apparatus
US8791435B2 (en) 2009-03-04 2014-07-29 Vladimir Egorovich Balakin Multi-field charged particle cancer therapy method and apparatus
US8841866B2 (en) 2008-05-22 2014-09-23 Vladimir Yegorovich Balakin Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system
US8896239B2 (en) 2008-05-22 2014-11-25 Vladimir Yegorovich Balakin Charged particle beam injection method and apparatus used in conjunction with a charged particle cancer therapy system
US8901509B2 (en) 2008-05-22 2014-12-02 Vladimir Yegorovich Balakin Multi-axis charged particle cancer therapy method and apparatus
US9058910B2 (en) 2008-05-22 2015-06-16 Vladimir Yegorovich Balakin Charged particle beam acceleration method and apparatus as part of a charged particle cancer therapy system

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1344781A1 (en) * 2002-03-12 2003-09-17 Laboratori Derivati Organici S.P.A. Process for the depolymerization of glycosaminoglycanes and products obtained therefrom
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
EP1524276A1 (en) * 2003-10-16 2005-04-20 Laboratori Derivati Organici S.P.A. Multistep process for the physical depolymerization of heparin and products obtained therefrom
US7939512B2 (en) 2004-10-13 2011-05-10 Laboratori Derivati Organici Spa Multistep process for the physical depolymerization of heparin and products obtained therefrom
DE602006016990D1 (de) 2005-12-22 2010-10-28 Bellus Health Int Ltd Behandlung von diabetischer nephropathie
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
ES2675993T3 (es) * 2011-10-14 2018-07-16 Centre National De La Recherche Scientifique Procedimiento de diagnóstico, pronóstico o tratamiento de enfermedades neurodegenerativas
CN112426434A (zh) * 2020-11-04 2021-03-02 山东大学 硫酸乙酰肝素在防治阿尔兹海默症中的应用
CN114478816A (zh) * 2022-02-11 2022-05-13 上海兴糖生物技术有限公司 一种白玉蜗牛多糖及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
EP0243974B1 (en) * 1986-05-01 1994-03-02 Toppan Printing Co., Ltd. Scanner set-up simulation apparatus
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
SK279285B6 (sk) * 1991-05-02 1998-09-09 Daiichi Pharmaceutical Co. Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8766217B2 (en) 2008-05-22 2014-07-01 Vladimir Yegorovich Balakin Multi-field charged particle cancer therapy method and apparatus
US8841866B2 (en) 2008-05-22 2014-09-23 Vladimir Yegorovich Balakin Charged particle beam extraction method and apparatus used in conjunction with a charged particle cancer therapy system
US8896239B2 (en) 2008-05-22 2014-11-25 Vladimir Yegorovich Balakin Charged particle beam injection method and apparatus used in conjunction with a charged particle cancer therapy system
US8901509B2 (en) 2008-05-22 2014-12-02 Vladimir Yegorovich Balakin Multi-axis charged particle cancer therapy method and apparatus
US9058910B2 (en) 2008-05-22 2015-06-16 Vladimir Yegorovich Balakin Charged particle beam acceleration method and apparatus as part of a charged particle cancer therapy system
US8791435B2 (en) 2009-03-04 2014-07-29 Vladimir Egorovich Balakin Multi-field charged particle cancer therapy method and apparatus

Also Published As

Publication number Publication date
NO328902B1 (no) 2010-06-14
DE60018061D1 (de) 2005-03-17
EP1181024A1 (en) 2002-02-27
NO20015544D0 (no) 2001-11-13
HK1039903A1 (en) 2002-05-17
AU4405200A (en) 2000-12-05
HK1039903B (en) 2005-08-26
HUP0201100A2 (hu) 2002-07-29
AU764743B2 (en) 2003-08-28
AU764743C (en) 2004-03-18
CZ20014092A3 (cs) 2002-04-17
PL352070A1 (en) 2003-07-28
PT1181024E (pt) 2005-06-30
CA2373975A1 (en) 2000-11-23
IT1312107B1 (it) 2002-04-04
ATE288761T1 (de) 2005-02-15
ES2237425T3 (es) 2005-08-01
HUP0201100A3 (en) 2003-03-28
PL198016B1 (pl) 2008-05-30
NO20015544L (no) 2002-01-14
US6979680B1 (en) 2005-12-27
EP1181024B1 (en) 2005-02-09
DK1181024T3 (da) 2005-06-13
CN1350459A (zh) 2002-05-22
DE60018061T2 (de) 2006-04-13
ITMI991066A1 (it) 2000-11-14
KR100711142B1 (ko) 2007-04-24
KR20020005033A (ko) 2002-01-16
JP2002544233A (ja) 2002-12-24
ZA200109331B (en) 2002-08-28
RU2248800C2 (ru) 2005-03-27
IL146458A0 (en) 2002-07-25
WO2000069444A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
CN1178667C (zh) 适用于治疗老年性痴呆的平均分子量为2400d的糖胺聚糖
CN1127517C (zh) 用于中枢神经系统再生的营养因子
JP2012527449A (ja) 退行性脳疾患を予防及び治療するためのハチ毒精製抽出物を含む組成物
JP2018154848A (ja) 低抗凝固剤ヘパリン
SK11782002A3 (sk) Metóda regulácie obsahu amyloidu
HRP20020721A2 (en) Novel method for down-regulation of amyloid
CN1615144A (zh) 治疗神经脑血管疾病的组合物
EP4001400B1 (en) Method for enhancing efficacy of stem cell by using ethionamide
CN1027895C (zh) 没有被非常规病毒污染的糖神经鞘脂混合物的制备与纯化方法
Kisilevsky et al. A critical analysis of postulated pathogenetic mechanisms in amyloidogenesis
CN1196734A (zh) 消炎药
CN1159015C (zh) 二苯乙烯甙在治疗痴呆症中的用途
CN101044161A (zh) 纯化的阿拉伯半乳聚糖－蛋白（agp）组合物
CN108743599A (zh) 一种化合物在减少蛋白聚积治疗老年痴呆方面的应用
KR101436728B1 (ko) 골수유래억제세포 및 레바미피드를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
US20200353007A1 (en) Pharmacological Composition for Prevention or Treatment of Lupus, Comprising Mesenchymal Stem Cell-Derived Secretome
CN1620303A (zh) 包含竹红天牛蛀屑作为活性成分的外用皮肤制剂
CN1347317A (zh) 药物
CN1686097A (zh) 一种含硫普罗宁的冻干组合物及其制备方法
CN1686534A (zh) 以垂体前叶肾上腺皮质提取物为主要成分的组合药物及其制备方法和用途
CN120154722A (zh) Gmfb在制备治疗外伤性视神经病变的药物中的应用
HUMAN THIRD INTERNATIONAL CONFERENCE ON ALZHEIMER’S DISEASE S83
Walzer Effects of low molecular weight glycosaminoglycans in amyloid beta-induced models of Alzheimer's disease
CN1317341A (zh) 一种十七肽的医药用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041208

Termination date: 20100512